DERMATITIS
Clinical trials for DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS trials appear
Sign up with your email to follow new studies for DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eczema drug shows promise in early trial
Disease control CompletedThis study tested a new medicine called camoteskimab in 62 adults with moderate to severe eczema (atopic dermatitis). The goal was to see if it could reduce skin redness, itching, and rash better than a placebo over 12 weeks. Participants received either the drug or a placebo, an…
Matched conditions: DERMATITIS
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
AI boosts skin diagnosis accuracy in small study
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) device could help doctors better identify skin conditions. Sixteen doctors (including general practitioners and dermatologists) reviewed 29 images of various skin issues, first giving a diagnosis on their own, then with th…
Matched conditions: DERMATITIS
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated May 22, 2026 13:53 UTC
-
Ear spray showdown: can ectoin soothe itchy ear canals?
Symptom relief CompletedThis study looked at two ear sprays, Ectoin and Normison, for people with chronic itching and eczema of the outer ear canal. Researchers observed 60 participants to see how well the sprays relieved symptoms and improved quality of life in real-world use. The goal was to compare t…
Matched conditions: DERMATITIS
Sponsor: Bitop AG • Aim: Symptom relief
Last updated May 26, 2026 07:52 UTC
-
New eczema drug for kids shows promise in itch relief
Symptom relief CompletedThis study tested a new medicine called TAU-284 in 303 children aged 7 to 15 with atopic dermatitis (eczema). The goal was to see if it could reduce itching better than an existing drug, ketotifen fumarate. Children took the medicine and reported their itch levels over time.
Matched conditions: DERMATITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated May 26, 2026 07:27 UTC